RA Capital Management - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$74,040,000
+94.9%
2,000,0000.0%1.58%
+56.0%
Q2 2022$37,980,000
-29.6%
2,000,0000.0%1.01%
-14.0%
Q1 2022$53,980,000
+19.8%
2,000,0000.0%1.18%
+48.4%
Q4 2021$45,060,000
+53.3%
2,000,000
+156.0%
0.79%
+47.6%
Q3 2020$29,392,000
-22.9%
781,290
-8.3%
0.54%
-27.6%
Q2 2020$38,123,000
-19.0%
851,907
-38.3%
0.74%
-50.0%
Q1 2020$47,071,000
+58.5%
1,379,988
+81.2%
1.49%
+65.0%
Q4 2019$29,705,000761,6660.90%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders